Search

everythinglearnresearchcommunity

for

Search:↓

Targeting specific T cells may help treat alopecia areata.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Hair follicles are key to treating vitiligo and alopecia areata, but challenges exist.

Alopecia Areata patients have too many Firmicutes and too few Bacteroides in their gut.

Melatonin reduced oxidative stress and might improve hair growth in alopecia areata patients.

Congenital alopecia areata may have genetic links and topical corticosteroids are an effective treatment.

Red blood cell folate levels are reliable indicators of long-term folate status in alopecia areata patients.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Trichohyalin may trigger the immune response causing alopecia areata.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Restoring hair follicle immune privilege may help treat alopecia areata.

Simvastatin/ezetimibe may help treat new cases of alopecia areata but not long-term cases.

Alopecia areata can be managed with various treatments, and severe cases should be referred to dermatologists.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Neurogenic inflammation may play a role in hair loss in alopecia areata.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Cryotherapy may help hair regrowth in alopecia areata with possibly lower relapse rates than steroids.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Targeting CXCL10 may help treat alopecia areata.

Hispanic/Latinx patients with alopecia areata often have it before age 40, with females and certain health conditions like rheumatoid arthritis more commonly affected.

Stem cells and their secretions could potentially treat stress-induced hair loss, but more human trials are needed.

Further research is needed to understand how the microbiome affects hair loss in Alopecia Areata.

Yellow dots and short vellus hairs are key signs for diagnosing alopecia areata using trichoscopy.

Platelet-Rich Plasma treatment improved hair growth and reduced inflammation in patients with patchy hair loss, but not in total hair loss, and Optical Coherence Tomography was useful in tracking this progress.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Pix Liquida helped a man recover from patchy hair loss.